William C. Stallings

6.4k total citations · 1 hit paper
66 papers, 5.1k citations indexed

About

William C. Stallings is a scholar working on Molecular Biology, Organic Chemistry and Inorganic Chemistry. According to data from OpenAlex, William C. Stallings has authored 66 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Organic Chemistry and 12 papers in Inorganic Chemistry. Recurrent topics in William C. Stallings's work include Metal-Catalyzed Oxygenation Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Analytical Chemistry and Chromatography (6 papers). William C. Stallings is often cited by papers focused on Metal-Catalyzed Oxygenation Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Analytical Chemistry and Chromatography (6 papers). William C. Stallings collaborates with scholars based in United States, United Kingdom and Switzerland. William C. Stallings's co-authors include Ravi G. Kurumbail, Martha Ludwig, Roderick A. Stegeman, Anna M. Stevens, K.A. Pattridge, James K. Gierse, Joseph J. McDonald, Peter C. Isakson, Thomas D. Penning and Karen Seibert and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

William C. Stallings

66 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1996 1.6k citations Ravi G. Kurumbail, Anna M. Stevens et al. Nature profile →

Peers

Countries citing papers authored by William C. Stallings

Since Specialization

Citations

This map shows the geographic impact of William C. Stallings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Stallings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Stallings more than expected).

Fields of papers citing papers by William C. Stallings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Stallings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Stallings. The network helps show where William C. Stallings may publish in the future.

Co-authorship network of co-authors of William C. Stallings

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Stallings. A scholar is included among the top collaborators of William C. Stallings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Stallings. William C. Stallings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure-based design and synthesis of pyrazinones containing novel P1 ‘side pocket’ moieties as inhibitors of TF/VIIa 2005 ·Bioorganic & Medicinal Chemistry Letters ·Barbara A. Schweitzer, William L. Neumann, (unknown), (unknown), (unknown), Gennadiy Poda, Ravi G. Kurumbail, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Michael S. South	13
2	Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex 2003 ·Bioorganic & Medicinal Chemistry Letters ·Michael S. South, Brenda L. Case, (unknown), Darin E. Jones, Michael Hayes, Thomas Girard, Rhonda M. Lachance, Nancy S. Nicholson, Michael Clare, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Ravi G. Kurumbail, John J. Parlow	32
3	A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385 2003 ·Journal of Biological Chemistry ·Scott W. Rowlinson, James R. Kiefer, Jeffery J. Prusakiewicz, Jennifer L. Pawlitz, Kevin R. Kozak, Amit S. Kalgutkar, William C. Stallings, Ravi G. Kurumbail, Lawrence J. Marnett	282
4	Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex 2003 ·Bioorganic & Medicinal Chemistry Letters ·John J. Parlow, Ravi G. Kurumbail, Roderick A. Stegeman, Anna M. Stevens, William C. Stallings, Michael S. South	19
5	Polymer-Assisted solution-Phase (PASP) parallel synthesis of an α-Ketothiazole library as tissue factor VIIa inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Michael S. South, (unknown), Thomas Girard, Rhonda M. Lachance, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Ravi G. Kurumbail, John J. Parlow	15
6	Structural insights into the stereochemistry of the cyclooxygenase reaction 2000 ·Nature ·James R. Kiefer, Jennifer L. Pawlitz, Kirby T. Moreland, Roderick A. Stegeman, William F. Hood, James K. Gierse, Anna M. Stevens, Douglas C. Goodwin, Scott W. Rowlinson, Lawrence J. Marnett, William C. Stallings, Ravi G. Kurumbail	212
7	Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents breakdown → 1996 ·Nature ·Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Joseph J. McDonald, Roderick A. Stegeman, (unknown), (unknown), (unknown), Thomas D. Penning, Karen Seibert, Peter C. Isakson, William C. Stallings	1559
8	Three-dimensional structure of human cytomegalovirus protease 1996 ·Nature ·Huey‐Sheng Shieh, Ravi G. Kurumbail, Anna M. Stevens, Roderick A. Stegeman, (unknown), (unknown), Arthur J. Wittwer, Mark O. Palmier, Roger C. Wiegand, Barry C. Holwerda, William C. Stallings	119
9	Using sampling techniques in protein crystallization 1995 ·Acta Crystallographica Section D Biological Crystallography ·H.-S. Shieh, William C. Stallings, (unknown), Roderick A. Stegeman	7
10	Inhibitors of HIV-1 Protease Containing the Novel and Potent (R)-(Hydroxyethyl)sulfonamide Isostere 1995 ·Journal of Medicinal Chemistry ·Michael L. Vazquez, Martin L. Bryant, Michael Clare, Gary DeCrescenzo, Elizabeth M. Doherty, John N. Freskos, Daniel P. Getman, Kathryn Houseman, (unknown), (unknown), Richard A. Mueller, Huey‐Sheng Shieh, William C. Stallings, Roderick A. Stegeman, (unknown)	37
11	STRUCTURE OF A THYMINE‐THYMINE ADDUCT FORMED BY MENADIONE PHOTOSENSITIZATION 1993 ·Photochemistry and Photobiology ·(unknown), William C. Stallings, Jenny P. Glusker	1
12	High-level production of active HIV-1 protease in Escherichia coli 1992 ·Gene ·Shaukat H. Rangwala, (unknown), Christine E. Smith, Sharon A. Berberich, W. J. Salsgiver, William C. Stallings, George I. Glover, Peter O. Olins	16
13	Structure-Function Relationships in Iron and Manganese Superoxide Dismutases 1991 ·Free Radical Research Communications ·William C. Stallings, A.L. Metzger, (unknown), James A. Fee, Martha Ludwig	72
14	Crystallization and preliminary X-ray characterization of a soybean seed lipoxygenase 1990 ·Journal of Molecular Biology ·William C. Stallings, (unknown), Richard T. Carroll, A.L. Metzger, Max O. Funk	15
15	Metal chelation versus internal hydrogen bonding of the .alpha.-hydroxy carboxylate group 1987 ·Journal of the American Chemical Society ·H. L. Carrell, Jenny P. Glusker, (unknown), William C. Stallings, David E. Zacharias, Rebecca L. Davis, (unknown), Colin H. L. Kennard	20
16	Intercalation Model for DNA-Cross Linking in a 1-Nitro-9-aminoacridine Derivative, an Analog of the Antitumor Agent “Ledakrin” (Nitracrine) 1984 ·Journal of Biomolecular Structure and Dynamics ·William C. Stallings, Jenny P. Glusker, H. L. Carrell, (unknown), (unknown), John J. Stezowski	6
17	Intermolecular interactions of the carbon-fluorine bond: the crystallographic environment of fluorinated carboxylic acids and related structures 1983 ·Journal of the American Chemical Society ·Peter Murray‐Rust, William C. Stallings, Claire T. Monti, Robert K. Preston, Jenny P. Glusker	276
18	The structure of a biological alkylating agent with antiumor properties: N-{2-[(chloroethyl)thio]ethyl}-10-methyl-9-anthracenemethylamine hydrochloride and of its selfalkylation product 10-methyl-9-[(4-thiomorpholino)methyl]anthracene 1982 ·Acta Crystallographica Section B ·William C. Stallings, Claire T. Monti, Jenny P. Glusker	1
19	Crystal and molecular structure of analgesics. II. Dezocine hydrobromide 1981 ·Journal of Chemical Crystallography ·Jerry Donohue, William C. Stallings	3
20	The carboxylation of biotin 1977 ·Archives of Biochemistry and Biophysics ·William C. Stallings	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact